Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Barker

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Neuropharmacology|September 2, 2008
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdownEkaterina A Placzek, Yasuo Okamoto, Natsuo Ueda, et al.
Journal of Reconstructive Microsurgery|August 26, 2017
Myocutaneous Gracilis Free Flaps in Microsurgical Breast Reconstruction: A Systematic Review Comparing Variations of the Upper Gracilis FlapVicky Kang, Emilie C Robinson, Eric L Barker, et al.
Biochemical Pharmacology|July 20, 2010
Conformational flexibility of transmembrane helix VII of the human serotonin transporter impacts ion dependence and transportCody J Wenthur, Gustavo J Rodríguez, Charles P Kuntz, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2008
Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognitionCrystal C Walline, David E Nichols, F Ivy Carroll, et al.
Protein Science : a Publication of the Protein Society|September 30, 2006
Engineered zinc-binding sites confirm proximity and orientation of transmembrane helices I and III in the human serotonin transporterKellie J White, Philip D Kiser, David E Nichols, et al.
European Journal of Pharmacology|November 13, 2003
Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysisDavid L Roman, Crystal C Walline, Gustavo J Rodriguez, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reservesDeborah M Kurrasch-Orbaugh, Val J Watts, Eric L Barker, et al.
The Journal of Biological Chemistry|March 23, 2010
Structural analysis of the extracellular entrance to the serotonin transporter permeation pathwayMelissa I Torres-Altoro, Charles P Kuntz, David E Nichols, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 20, 2012
4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogsVida Zohrabi-Kalantari, Abbas Jarrahian, Caterina Bissantz, et al.
Psychopharmacology|September 15, 2010
Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preferenceMatthew S Powers, Gustavo D Barrenha, Nate S Mlinac, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Neuropharmacology|September 2, 2008
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdownEkaterina A Placzek, Yasuo Okamoto, Natsuo Ueda, et al.
Journal of Reconstructive Microsurgery|August 26, 2017
Myocutaneous Gracilis Free Flaps in Microsurgical Breast Reconstruction: A Systematic Review Comparing Variations of the Upper Gracilis FlapVicky Kang, Emilie C Robinson, Eric L Barker, et al.
Biochemical Pharmacology|July 20, 2010
Conformational flexibility of transmembrane helix VII of the human serotonin transporter impacts ion dependence and transportCody J Wenthur, Gustavo J Rodríguez, Charles P Kuntz, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2008
Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognitionCrystal C Walline, David E Nichols, F Ivy Carroll, et al.
Protein Science : a Publication of the Protein Society|September 30, 2006
Engineered zinc-binding sites confirm proximity and orientation of transmembrane helices I and III in the human serotonin transporterKellie J White, Philip D Kiser, David E Nichols, et al.
European Journal of Pharmacology|November 13, 2003
Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysisDavid L Roman, Crystal C Walline, Gustavo J Rodriguez, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reservesDeborah M Kurrasch-Orbaugh, Val J Watts, Eric L Barker, et al.
The Journal of Biological Chemistry|March 23, 2010
Structural analysis of the extracellular entrance to the serotonin transporter permeation pathwayMelissa I Torres-Altoro, Charles P Kuntz, David E Nichols, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 20, 2012
4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogsVida Zohrabi-Kalantari, Abbas Jarrahian, Caterina Bissantz, et al.
Psychopharmacology|September 15, 2010
Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preferenceMatthew S Powers, Gustavo D Barrenha, Nate S Mlinac, et al.
Pageof 4